临床外科杂志 ›› 2021, Vol. 29 ›› Issue (3): 248-252.doi: 10.3969/j.issn.1005-6483.2021.03.013

• • 上一篇    下一篇

miR-597调控FOSL2抑制乳腺癌细胞增殖、迁移及侵袭的研究

  

  1. 570206 海口,海南省妇女儿童医学中心乳腺外科
  • 出版日期:2021-03-20 发布日期:2021-03-20

miR-597 inhibits breast cancer cell proliferation,migration and invasion through FOSL2

  1. Department of Breast Surgery,Hainan Women and Children Medical Center,Hainan,Haikou 570206, China
  • Online:2021-03-20 Published:2021-03-20

摘要: 目的  探讨miR-597对乳腺癌细胞增殖、迁移及侵袭的影响,及其与FOS 样抗原 2(Fos-related antigen 2,FOSL2)的靶向关系。
方法  选取乳腺癌细胞株T-47D,SK-BR-3,MDA-MB-231,MCF7及BT-474,正常乳腺细胞株MCF10A为研究对象,分别转染miR-597(miR-597组)及 RNA 阴性对照序列(NC组),同时选取30例乳腺癌病人癌组织及癌旁正常乳腺组织,迅速液氮冻存以提取RNA用于qRT-PCR检测。采用实时荧光定量 PCR 法检测细胞、组织中miR-597表达水平;MTT、流式细胞术检测细胞增殖能力;Transwell小室实验检测细胞迁移、侵袭能力;Western blot检测细胞FOSL2表达水平;生物信息预测miR-597与FOSL2的靶向作用关系,荧光素酶实验验证。
结果  乳腺癌组织miR-597水平低于正常乳腺组织,乳腺癌细胞株细胞miR-597表达低于正常乳腺细胞株细胞,差异有统计学意义(P<0.01);miR-597组细胞增殖能力明显低于NC组,差异有统计学意义(t=9.833,P=0.003),miR-597组G0G1期细胞百分率高于NC组,S期细胞百分率低于NC组(t=10.215,10.336,P=0.000,0.000);miR-597组细胞侵袭能力低于NC组(t=8.404,P=0.000),miR-597组细胞迁移能力低于NC组(t=5.801,P=0.016);miR-597组细胞FOSL2表达水平低于NC组(t=13.658,P=0.000);miR-597与FOSL2有良好的靶向关系。
结论  miR-597在乳腺癌组织及细胞株中低表达,其高表达可可抑制乳腺癌细胞的增殖、迁移及侵袭能力,其机制与调控FOSL2有关。

关键词: miR-597, FOS样抗原2, 乳腺癌, 转移, 侵袭

Abstract: Objective  To investigate the effect of miR-597 on the proliferation,migration and invasion of breast cancer cells,and its relationship with FOS related antigen 2(FOSL2).
Methods  Breast cancer cell lines T-47D,SK-BR-3,MDA-MB-231,MCF7,BT-474 and normal breast cell line MCF10A were selected as the study objects.According to the transfection,it was divided into:NC group(null plasmid) and miR-597 group(simulated sequence).Meanwhile,30 patients with breast cancer tissue and normal breast tissue adjacent to cancer were selected,rapid cryopreservation of liquid nitrogen to extract RNA for qRT-PCR.The expression level of miR-597 in cells and tissues was detected by real-time fluorescence quantitative PCR.The cell proliferation was detected by MTT and flow cytometry.The cell migration and invasion were detected by Transwell chamber.The expression of FOSL2 was detected by Western blot.The target effect of miR-597 and FOSL2 was confirmed by bioinformatics methodsand the luciferase reporter assay.
Results  The expression of miR-597 in breast cancer tissue was lower than that in normal breast tissue(P<0.01).The  cell proliferation ability of miR-597 in breast cancer cell line was lower than that in normal breast cell line(P<0.01).The percentage of G0G1 phase cells in miR-597 group was higher than that in NC group,and the percentage of S-phase cells was lower than that in NC group(t=10.215,10.336,P=0.000,0.000).The cell invasion ability of miR-597 group was lower than that of NC group(t=8.404,P=0.000).The cell migration ability of miR-597 group was lower than that of NC group(t=5.801,P=0.016).The expression level of FOSL2 in miR-597 group was lower than that of NC group(t=13.658,P=0.000).MiR-597 had a good targeting relationship with FOSL2.
Conclusion  miR-597 was low expressed in breast cancer tissue and cell lines.The high expression of miR-597 can inhibit the proliferation,migration and invasion of breast cancer cells,and which was related to the regulation of FOSL2.

Key words: miR-597, Fos like antigen 2, breast cancer, metastasis, invasion

[1] 蔡耿喜 刘强. 乳腺癌的精准治疗[J]. 临床外科杂志, 2021, 29(3): 201-207.
[2] 刘健 吴凡. 精准医学对乳腺癌化疗方案选择的积极意义[J]. 临床外科杂志, 2021, 29(3): 208-211.
[3] 王朝斌 王殊. 乳腺癌保留腋窝的临床试验进展[J]. 临床外科杂志, 2021, 29(3): 212-214.
[4] 马天怡 王海波. 肿瘤整形技术在保乳手术中的应用与进展[J]. 临床外科杂志, 2021, 29(3): 215-217.
[5] 黄春旺 丛淑珍. 非典型乳腺癌超声诊断的要点及难点[J]. 临床外科杂志, 2021, 29(3): 218-221.
[6] 任敏 徐云凤. 乳腺癌乳房成形手术方法的精准选择[J]. 临床外科杂志, 2021, 29(3): 222-225.
[7] 戴嘉婧 韩馨乐 钟福波 林哲广 江淑琪 韦伟 方征宇. 三阴性乳腺癌与癌旁组织中差异表达环状RNA筛选及生物信息学分析[J]. 临床外科杂志, 2021, 29(3): 227-230.
[8] 杨丽 朱荔 刘紫朦 鲍宝石 马金平 王建东. 超声引导下空芯针穿刺活检对乳腺癌的诊断价值[J]. 临床外科杂志, 2021, 29(3): 231-234.
[9] 聂丽静 奚凯雯 韦嘉玲 董晓晶 方琼 金玉翡. 个案管理模式下乳腺癌病人辅助内分泌治疗依从性分析[J]. 临床外科杂志, 2021, 29(3): 235-238.
[10] 黄雅静 吴昊 罗智勇. 乳腺癌术后一步法与二步法重建乳房的临床效果分析[J]. 临床外科杂志, 2021, 29(3): 239-242.
[11] 张振伟 孙家和 张立功 钱军. 乳腺癌骨转移病人危险因素及预后因素分析[J]. 临床外科杂志, 2021, 29(3): 243-247.
[12] 段书强 鲍方 刘振邦 王菲 高慧敏 开蕾. 趋化因子配体12/趋化因子受体4轴在三阴性乳腺癌组织中表达及与淋巴结转移关系[J]. 临床外科杂志, 2021, 29(3): 254-257.
[13] 闫军 周高晋. 乳腺癌外周血单核细胞自噬相关基因表达及其与肿瘤复发的关系[J]. 临床外科杂志, 2021, 29(3): 258-260.
[14] 李颖 董明华 张萌萌 孟芳 杨晓慧. 低频超声微泡增强紫杉醇诱导三阴性乳腺癌细胞自噬的作用及机制[J]. 临床外科杂志, 2021, 29(3): 261-264.
[15] 李金穗 周瑶 蒲卢兰 徐明飞 侯令密 高砚春. 混合核苷片预防乳腺癌表柔比星+环磷酰胺方案辅助化疗所致骨髓抑制的临床研究[J]. 临床外科杂志, 2021, 29(3): 265-268.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 徐媛;宋亚锋;许涛. 谷氨酰胺并肠外营养支持在外科术后危重患者中的应用[J]. 临床外科杂志, 2016, 24(12): 914 .
[2] 唐文 拜都如拉·艾尼吐 付毅等. 肺结核大咯血27例急诊外科治疗分析[J]. 临床外科杂志, 2016, 24(9): 725 .
[3] 秦新裕;许剑民;任黎;等. 中国《结直肠癌肝转移诊断和综合治疗指南(V 2016)》解析[J]. 临床外科杂志, 2017, 25(1): 15 .
[4] 张克明;赵新;洪智贤;等. 术中超声在亚肝段为主的肝切除治疗肝癌合并门静脉高压症中的应用价值[J]. 临床外科杂志, 2017, 25(3): 198 .
[5] 喻少敏;郭卫春. 二十二碳六烯酸在急性脊髓损伤后早期炎性反应中的作用[J]. 临床外科杂志, 2017, 25(4): 301 .
[6] 吴浩;苏小虎;易文波等. 支气管封堵器隔离左肺盲探插管方法的应用[J]. 临床外科杂志, 2018, 26(1): 61 .
[7] 赵文斌 凃峰 王浩 张晨. 肩胛下肌损伤的关节镜下治疗[J]. 临床外科杂志, 2018, 26(10): 787 -788 .
[8] 何静婷;喻姣花;王思桦. 主动呼吸循环技术促进肺癌术后患者肺复张的效果分析[J]. 临床外科杂志, 2018, 26(3): 208 .
[9] 刘恒;董懿;王钢乐. Mammotome微创旋切活检术对乳腺恶性肿瘤的临床诊治价值分析[J]. 临床外科杂志, 2018, 26(5): 366 .
[10] 石奎 贾洪峰. 七氟烷吸入麻醉对开胸手术病人术后血清cTnI及心肌酶水平的影响作用探讨[J]. 临床外科杂志, 2018, 26(11): 871 -873 .